Skip to content
COVID-19 has affected the world for nearly four years, persisting in its consequences through post-viral syndrome. Scientists are gaining deeper insights into the causes […]
Unraveling causes of long COVID to find potential treatments Read More »
A boy with a rare genetic condition has regained his sight thanks to creative “off-label” use of a gene therapy—an innovative approach that current
Off-label use of a gene therapy returns sight for boy with rare disease Read More »
On July 20, seven pharmaceutical companies announced the formation of a new international alliance to help prepare the world for the next pandemic –
INTREPID Alliance seeks 25 new pandemic-ready antivirals Read More »
Already a leader in biotech for agriculture, Bayer announced plans to double its Crop Sciences Division with a major push into regenerative farming. Along
Bayer digs into regenerative farming through biotech Read More »
Heart disease remains the leading cause of death in the United States. According to the American Heart Association (AHA), in 2020, cardiovascular disease (CVD)
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House
PAHPA legislation moves forward in Senate and House Read More »
With over 6 million unintended pregnancies in the U.S. each year and birth rates on the rise since 2021, making it easy to obtain
FDA approves first over-the-counter birth control pill Read More »
We see a great demand for effective therapies, particularly for conditions with limited treatment options. Transformative treatments, no matter how small, have the impact
3 things to know about the future of small molecule therapeutics Read More »
On July 17, Eli Lilly announced positive results from clinical trials of donanemab, the company’s candidate for the treatment of Alzheimer’s disease. The drug
Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline Read More »
In the latest bioscience victory over viruses, the Food and Drug Administration (FDA) on July 17 gave the first approval to a monoclonal antibody
FDA approves monoclonal antibody to protect infants from RSV Read More »
